Epidemiology of vitiligo, associated autoimmune diseases and audiological abnormalities: Ankara study of 80 patients in Turkey

Journal of the European Academy of Dermatology and Venereology

Volumn 24, Issue 10, 2010, Pages 1144-1150

  Akay, B N ^a   Bozkir, M ^b   Anadolu, Y ^a   Gullu, S ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b Türktelekom Co   (Turkey)

Author keywords

audiometry; autoimmune; hearing loss; HLA; vitiligo

Indexed keywords

HLA A24 ANTIGEN; HLA A30 ANTIGEN; HLA B63 ANTIGEN; HLA CW6 ANTIGEN; HLA DQ5 ANTIGEN; HLA DQ6 ANTIGEN; HLA DR15 ANTIGEN; HLA DR51 ANTIGEN; LEUKOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALOPECIA AREATA; ARTICLE; AUDIOMETRY; AUDITORY SYSTEM FUNCTION; AUTOIMMUNE DISEASE; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; FEMALE; GENETIC ANALYSIS; HASHIMOTO DISEASE; HEARING LOSS; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATHOGENESIS; PERNICIOUS ANEMIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; TURKEY (REPUBLIC); VITILIGO;

ADULT; ALOPECIA; ANEMIA, PERNICIOUS; AUTOIMMUNE DISEASES; COMORBIDITY; DIABETES MELLITUS; FEMALE; HASHIMOTO DISEASE; HEARING LOSS; HUMANS; MALE; RETROSPECTIVE STUDIES; TURKEY; VITILIGO;

EID: 77956297900     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2010.03605.x     Document Type: Article

References (51)

1. Hann S-K, Nordlund JJ. Definition of Vitiligo. In Hann S-K, Nordlund JJ eds. Vitiligo: A Monograph on the Basic and Clinical Science. Blackwell Science, Oxford, 2000 : 3 5.
2. Bulbul EB, Baykara M, Ercan I, Tunali S, Yucel A. Vitiligo and ocular findings: a study on possible associations. J Eur Acad Dermatol Venereol 2006 20 : 829 833.
3. Biswas G, Barbhuiya JN, Biswas MC, Islam MN, Dutta S. Clinical pattern of ocular manifestations in vitiligo. J Indian Med Assoc 2003 101 : 478 480.
4. Sun X, Xu A, Wei X et al. Study on genetic epidemiology in 815 patients with vitiligo in Zhejiang area. J Eur Acad Dermatol 2005 26 : 911 914.
5. Arican O, Koc K, Kutluk R, Ersoy L. Vitiligolu hastalarda serum vitamin B12 ve folik asit düzeyleri. Türkiye Klinikleri Dermatol 2003 13 : 4 10.
6. Majumder PP, Das SK, Li CC. A genetical model for vitiligo. Am J Human Genet 1988 43 : 119 125.
7. Bhatia PS, Mohan L, Pandey ON et al. Genetic nature of vitiligo. J Dermatol Sci 1992 4 : 180 184.
8. Nath SK, Majumder PP, Nordlund JJ. Genetic epidemiology of vitiligo. Arch Dermatol 1993 129 : 994 998.
9. Ortonne JP, Bahodoran P, Fitzpatrick TB et al. Hypomelanoses and hypermelanoses. In Freedberg IM, Eisen AZ, Wolff K et al. eds. Fitzpatrick's Dermatology in General Medicine, 6th edn. Mc Graw Hill, New York, 2003 : 893 947.
10. Lomoreux L, Boissy RE. Animal models. In Hann SK, Nordlund JJ eds. Vitiligo: A monograph on the Basic and Clinical Science. Oxford, Blackwell Science, 2000 : 281 295.
11. Aydogan K, Turan OF, Onart S et al. Audiological abnormalities in patients with vitiligo. Clin Exp Dermatol 2006 31 : 110 113.
12. Tosti A, Bardazzi F, Tosti G, Monti L. Audiologic abnormalities in cases of vitiligo. J Am Acad Dermatol 1987 17 : 230 233.
13. Ozuer MZ, Sahiner T, Aktan S et al. Auditory evoked potentials in vitiligo patients. Scand Audiol 1998 27 : 255 258.
14. Gopal KV, Rama Rao GR, Kumar YH et al. Vitiligo: a part of a systemic autoimmune process. Indian J Dermatol Venereol Leprol 2007 73 : 162 165.
15. Hong CK, Lee MH, Jeong KH et al. Clinical analysis of hearing levels in vitiligo patients. Eur J Dermatol 2009 19 : 50 56.
16. Alkhateeb A, Fain PR, Thody A et al. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 2003 16 : 208 214.
17. Kovacs SO. Vitiligo. J Am Acad Dermatol 1998 38 : 647 666.
18. Dave S, D'Souza M, Thappa DM et al. High frequency of thyroid dysfunction in Indian patients with vitiligo. Indian J Dermatol 2003 48 : 68 72.
19. Schallreuter KU, Lemke R, Branddt O et al. Vitiligo and other diseases: coexistence of true association? Hamburg study on 321 patients Dermatology 1994 188 : 269 275.
20. Spritz RA. The genetics of generalized vitiligo and associated autoimmune diseases. J Dematol Sci 2006 41 : 3 10.
21. Hsin-Su Yu. Melanocyte destruction and repigmentation in vitiligo: a model for nerve cell damage and regrowth. J Biomed Sci 2002 9 : 564 573.
22. Hann SK, Chun WH. Autocytotoxic hypothesis for the destruction of melanocytes as the cause of vitiligo. In Hann SK, Nordlund JJ eds. Vitiligo. Blackwell Science, Oxford, 2000 : 137 141.
23. Halder RM, Grimes PE, Cowan CA et al. Childhood vitiligo. J Am Acad Dermatol 1987 16 : 948 954.
24. Jaisankar TJ, Baruah MC, Garg BR. Vitiligo in children. Int J Dermatol 1992 31 : 621 623.
25. Handa S, Dogra S. Epidemiology of childhood vitiligo: a study of 625 patients from north India. Pediatr Dermatol 2003 20 : 207 210.
26. Handa S, Kaur I. Vitiligo: clinical findings in 1436 patients. J Dermatol 1999 26 : 1295 1297.
27. Dogra S, Parsad D, Handa S, Kanwar JA. Late onset vitiligo: a study of 182 patients. Int J Dermatol 2005 44 : 193 196.
28. Akrem J, Baroudi A, Aichi T et al. Profile of vitiligo in the south of Tunisia. Int J Dermatol 2008 47 : 670 674.
29. Hann SK, Chun WH, Park YK. Clinical characteristics of progressive vitiligo. Int J Dermatol 1997 36 : 353 355.
30. Liu JB, Li M, Yang S et al. Clinical profiles of vitiligo in China: an analysis of 3742 patients. Clin Exp Dermatol 2005 30 : 327 331.
31. Song MS, Hann SK, Ahn PS et al. Clinical study of vitiligo: comparative study of type A and type B vitiligo. Ann Dermatol (Seoul) 1994 6 : 22 30.
32. al-Fouzan A, al-Arbash M, Fouad F et al. Study of HLA class I/II and T lymphocyte subsets in Kuwaiti vitiligo patients. Eur J Immunogenet 1995 22 : 209 213.
33. Buc M, Busova B, Hegyi E et al. Vitiligo is associated with HLA-A2 and HLA-Dw7 in the Slovak population. Folia Biol (Praha) 1996 42 : 23 25.
34. Dunston GM, Halder RM. Vitiligo is associated with HLA-DR4 in black patients: a preliminary report. Arch Dermatol 1990 126 : 56 60.
35. Finco O, Cuccia M, Martinetti M et al. Age of onset in vitiligo: relationship with HLA supratypes. Clin Genet 1991 39 : 48 54.
36. Foley LM, Lowe NJ, Misheloff E, Tiwari JL. Association of HLA-DR4 with vitiligo. J Am Acad Dermatol 1983 8 : 39 40.
37. Lorini R, Orecchia G, Martinetti M et al. Autoimmunity in vitiligo: relationship with HLA, Gm and Km polymorphisms. Autoimmunity 1992 11 : 255 260.
38. Metzker A, Zamir R, Gazit E et al. Vitiligo and the HLA system. Dermatologica 1980 160 : 100 105.
39. Orecchia G, Perfetti L, Malagoli P et al. Vitiligo is associated with a significant increase in HLA-A30, Cw6 and DQw3 and a decrease in C4AQ0 in northern Italian patients. Dermatology 1992 185 : 123 127.
40. Poloy A, Tibor L, Kramer J et al. HLA-DR1 is associated with vitiligo. Immunol Lett 1991 27 : 59 62.
41. Schallreuter KU, Levenig C, Kühnl P et al. Histocompatibility antigens in vitiligo: Hamburg study on 102 patients from northern Germany. Dermatology 1993 187 : 186 192.
42. Venneker GT, De Waal LP, Westerhof W et al. HLA associations in vitiligo patients in the Dutch population. Dis Markers 1993 11 : 187 190.
43. Venkataram MN, White AG, Leeny WA et al. HLA antigens in Omani patients with vitiligo. Clin Exp Dermatol 1995 20 : 35 37.
44. Tastan HB, Akar A, Orkunoglu FE et al. Association of HLA class 1 antigens and HLA class 2 alleles with vitiligo in a Turkish Population. Pigment Cell Res 2004 17 : 181 184.
45. Kurtev A, Dourmishev AL. Thyroid function and autoimmunity in children and adolescents with vitiligo. J Eur Acad Dermatol Venereol 2004 18 : 99 117.
46. Tunc R, Gonen MS, Acbay O et al. Autoimmune thyroiditis and anti-thyroid antibodies in primary Sjogren's syndrome: a case-control study. Ann Rheum Dis 2004 63 : 575 577.
47. Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Skin Immunol Immunopath 1997 84 : 223 243.
48. Onat A, Hergenc G, Uyarel H et al. Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey. Anadolu Kardiyoloji Derg 2006 6 : 314 321.
49. Behl PN, Bhatia RK. 400 cases of vitiligo. A clinico-therapeutic analysis. Indian J Dermatol 1972 17 : 51 55.
50. Koo SW, Suh CO, Hann SK. Vitiligo following radiotherapy following radiotherapy for carcinoma of breast. Br J Dermatol 1996 135 : 852 853.
51. Escalante-Ugalde C, Poblano A, Montes de Oca E et al. No evidence of hearing loss in patients with vitiligo. Arch Dermatol 1991 127 : 1240.